Cargando…

A Multi-Compartment, Single and Multiple Dose Pharmacokinetic Study of the Vaginal Candidate Microbicide 1% Tenofovir Gel

BACKGROUND: Tenofovir (TFV) gel is being evaluated as a microbicide with pericoital and daily regimens. To inhibit viral replication locally, an adequate concentration in the genital tract is critical. METHODS AND FINDINGS: Forty-nine participants entered a two-phase study: single-dose (SD) and mult...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schwartz, Jill L., Rountree, Wes, Kashuba, Angela D. M., Brache, Vivian, Creinin, Mitchell D., Poindexter, Alfred, Kearney, Brian P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3198383/ https://www.ncbi.nlm.nih.gov/pubmed/22039430 http://dx.doi.org/10.1371/journal.pone.0025974

Ejemplares similares

Vaginal deployment and tenofovir delivery by microbicide gels
por: Gao, Y., et al.
Publicado: (2015)

A Multi-Compartment Single and Multiple Dose Pharmacokinetic Comparison of Rectally Applied Tenofovir 1% Gel and Oral Tenofovir Disoproxil Fumarate
por: Yang, Kuo-Hsiung, et al.
Publicado: (2014)

Vaginal microbiota and mucosal pharmacokinetics of tenofovir in healthy women using tenofovir and tenofovir/levonorgestrel vaginal rings
por: Thurman, Andrea Ries, et al.
Publicado: (2019)

MTN-001: Randomized Pharmacokinetic Cross-Over Study Comparing Tenofovir Vaginal Gel and Oral Tablets in Vaginal Tissue and Other Compartments
por: Hendrix, Craig W., et al.
Publicado: (2013)

Multicompartmental Pharmacokinetic Model of Tenofovir Delivery by a Vaginal Gel
por: Gao, Yajing, et al.
Publicado: (2013)

Randomized, placebo controlled phase I trial of safety, pharmacokinetics, pharmacodynamics and acceptability of tenofovir and tenofovir plus levonorgestrel vaginal rings in women
por: Thurman, Andrea Ries, et al.
Publicado: (2018)

Brief Report: Selection of HIV-1 Variants With Higher Transmission Potential by 1% Tenofovir Gel Microbicide
por: Ngandu, Nobubelo K., et al.
Publicado: (2017)

Quantitative Analysis of Microbicide Concentrations in Fluids, Gels and Tissues Using Confocal Raman Spectroscopy
por: Chuchuen, Oranat, et al.
Publicado: (2013)

Vaginal Microbiota and Mucosal Pharmacokinetics of Tenofovir in Healthy Women Using a 90-Day Tenofovir/Levonorgestrel Vaginal Ring
por: Thurman, Andrea R., et al.
Publicado: (2022)

Enzyme Responsive Vaginal Microbicide Gels Containing Maraviroc and Tenofovir Microspheres Designed for Acid Phosphatase-Triggered Release for Pre-Exposure Prophylaxis of HIV-1: A Comparative Analysis of a Bigel and Thermosensitive Gel
por: Ekama, Sabdat Ozichu, et al.
Publicado: (2021)

Vaginal rings for delivery of HIV microbicides
por: Malcolm, R Karl, et al.
Publicado: (2012)

Acceptability of Carraguard Vaginal Microbicide Gel among HIV-Infected Women in Chiang Rai, Thailand
por: Whitehead, Sara J., et al.
Publicado: (2011)

A randomized safety and pharmacokinetic trial of daily tenofovir 1% gel in term and near-term pregnancy
por: Beigi, Richard H, et al.
Publicado: (2016)

Safety and Pharmacokinetics of a Tenofovir Alafenamide Fumarate-Emtricitabine based Oral Antiretroviral Regimen for Prevention of HIV Acquisition in Women: A Randomized Controlled Trial
por: Thurman, Andrea R., et al.
Publicado: (2021)

Randomized, placebo controlled phase I trial of the safety, pharmacokinetics, pharmacodynamics and acceptability of a 90 day tenofovir plus levonorgestrel vaginal ring used continuously or cyclically in women: The CONRAD 138 study
por: Thurman, Andrea R., et al.
Publicado: (2022)

In Vitro and Ex Vivo Testing of Tenofovir Shows It Is Effective As an HIV-1 Microbicide
por: Rohan, Lisa C., et al.
Publicado: (2010)

The Development of Vaginal Microbicides for the Prevention of HIV Transmission
por: Weber, Jonathan, et al.
Publicado: (2005)

Infrequent, low magnitude HIV-specific T cell responses in HIV-uninfected participants in the 1% tenofovir microbicide gel trial (CAPRISA004)
por: Burgers, WA, et al.
Publicado: (2012)

Measuring Dilution of Microbicide Gels with Optical Imaging
por: Drake, Tyler K., et al.
Publicado: (2013)

Potential role of tenofovir vaginal gel for reduction of risk of herpes simplex virus in females
por: Tan, DHS
Publicado: (2012)

Acceptability of Carraguard, a candidate microbicide and methyl cellulose placebo vaginal gels among HIV-positive women and men in Durban, South Africa
por: Ramjee, Gita, et al.
Publicado: (2007)

VivaGel(™) (SPL7013 Gel): A candidate dendrimer – microbicide for the prevention of HIV and HSV infection
por: Rupp, Richard, et al.
Publicado: (2007)

Potential Use of Antimicrobial Peptides as Vaginal Spermicides/Microbicides
por: Tanphaichitr, Nongnuj, et al.
Publicado: (2016)

FAME‐04: A Phase 1 trial to assess the safety, acceptability, pharmacokinetics and pharmacodynamics of film and gel formulations of tenofovir
por: Bunge, Katherine E, et al.
Publicado: (2018)

SAVVY Vaginal Gel (C31G) for Prevention of HIV Infection: A Randomized Controlled Trial in Nigeria
por: Feldblum, Paul J., et al.
Publicado: (2008)

Microbicides Development Programme: Engaging the community in the standard of care debate in a vaginal microbicide trial in Mwanza, Tanzania
por: Vallely, Andrew, et al.
Publicado: (2009)

Efficacy of Tenofovir 1% Vaginal Gel in Reducing the Risk of HIV-1 and HSV-2 Infection
por: McConville, Christopher, et al.
Publicado: (2014)

Efficacy, Stability, and Biosafety of Sifuvirtide Gel as a Microbicide Candidate against HIV-1
por: Li, Liangzhu, et al.
Publicado: (2012)

Genital inflammation undermines the effectiveness of tenofovir gel in preventing HIV acquisition in women
por: McKinnon, Lyle R., et al.
Publicado: (2018)

Efficacy dilution in randomized placebo-controlled vaginal microbicide trials
por: Mâsse, Benoît R, et al.
Publicado: (2009)

Twice-Daily Application of HIV Microbicides Alters the Vaginal Microbiota
por: Ravel, Jacques, et al.
Publicado: (2012)

Do vaginal microbicides reduce the risk of HIV acquisition in women?
por: Obiero, Jael Apondi, et al.
Publicado: (2022)

Population pharmacokinetics of tenofovir and tenofovir‐diphosphate in healthy women
por: Burns, Rebecca N., et al.
Publicado: (2015)

Project Gel a Randomized Rectal Microbicide Safety and Acceptability Study in Young Men and Transgender Women
por: McGowan, Ian, et al.
Publicado: (2016)

Vaccine plus microbicide effective in preventing vaginal SIV transmission in macaques
por: Rahman, Mohammad Arif, et al.
Publicado: (2023)

Differences in Local and Systemic TFV PK Among Premenopausal Versus Postmenopausal Women Exposed to TFV 1% Vaginal Gel
por: Thurman, Andrea Ries, et al.
Publicado: (2018)

Population pharmacokinetics of tenofovir given as either tenofovir disoproxil fumarate or tenofovir alafenamide in an African population
por: Kawuma, Aida N., et al.
Publicado: (2023)

Mucosal effects of tenofovir 1% gel
por: Hladik, Florian, et al.
Publicado: (2015)

Vaginal microbicides: detecting toxicities in vivo that paradoxically increase pathogen transmission
por: Cone, Richard A, et al.
Publicado: (2006)

Analysis of Vaginal Microbicide Film Hydration Kinetics by Quantitative Imaging Refractometry
por: Rinehart, Matthew, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_nr5edlsvornd4l23j565iuvmjo